drugset / Trial / NCT00806754

Investigation of the Efficacy and Safety of Concomitant Administration of Ciclesonide Nasal Spray and Azelastine Nasal Spray in Patients (18 Years or Older) With Perennial Allergic Rhinitis (PAR) Not Adequately Controlled on an Intranasal Corticosteroid or Antihistamine Monotherapy (BY9010/M1-490)

NCT00806754

Phase 4 Completed 340 enrolled AstraZeneca
RandomizedParallel-groupTriple-blindTreatment

Summary

* The primary objective of this study is to evaluate the efficacy of the concomitant administration of ciclesonide nasal spray and azelastine nasal spray versus ciclesonide nasal spray alone in patients (18 years or older) with perennial allergic rhinitis (PAR) not adequately controlled on an intranasal corticosteroid or antihistamine monotherapy * The secondary objective is to investigate the safety of the concomitant administration of ciclesonide nasal spray and azelastine nasal spray

Timeline

Start
2006-11
Primary completion
2007-05
Completion
2007-08

Drugs

EvaluationDrugModalityDoseRoute
Comparator Azelastine Small molecule 137 ug Intranasal
Comparator Ciclesonide Other / unclassified 50 ug Intranasal